Human metabolic response to systemic inflammation: assessment of the concordance between experimental endotoxemia and clinical cases of sepsis/SIRS

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Kamisoglu, Kubra ^a   Haimovich, Beatrice ^b   Calvano, Steve E ^b   Coyle, Susette M ^b   Corbett, Siobhan A ^b   Langley, Raymond J ^c   Kingsmore, Stephen F ^d,e   Androulakis, Ioannis P ^a,b,f  

^a The State University of New Jersey   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d Children's Mercy Center for Pediatric Genomic Medicine   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; AMINO ACID; CARBOHYDRATE; ELECTROLYTE; LIPID;

ADULT; APACHE; ARTICLE; BODY WEIGHT; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EXPERIMENTAL ENDOTOXEMIA; HOSPITAL ADMISSION; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; BLOOD; ENDOTOXEMIA; INFLAMMATION; LIPID METABOLISM; PHYSIOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AMINO ACIDS; CARBOHYDRATES; ELECTROLYTES; ENDOTOXEMIA; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPIDS; LIPOPOLYSACCHARIDES; METABOLOME; RETROSPECTIVE STUDIES; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84925962500     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0783-2     Document Type: Article

References (41)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-6.
2. Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief. 2011;62:1-8.
3. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-51.
4. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40:754-61.
5. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25:609-34.
6. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol. 2007;81:137-43.
7. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock. 1998;9:1-11.
8. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 2005;4:854-65.
9. Munford RS. Detoxifying endotoxin: time, place and person. J Endotoxin Res. 2005;11:69-84.
10. Wolff SM. Biological effects of bacterial endotoxins in man. J Infect Dis. 1973;128:259-64.
11. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K. Human endotoxemia as a model of systemic inflammation. Curr Med Chem. 2008;15:1697-705.
12. Lin E, Lowry S. The human response to endotoxin. Sepsis. 1998;2:255-62.
13. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock. 2005;24:94-100.
14. Calvano SE, Coyle SM. Experimental human endotoxemia: a model of the systemic inflammatory response syndrome? Surg Infect (Larchmt). 2012;13:293-9.
15. Haimovich B, Reddell MT, Calvano JE, Calvano SE, Macor MA, Coyle SM, et al. A novel model of common Toll-like receptor 4- and injury-induced transcriptional themes in human leukocytes. Crit Care. 2010;14:R177.
16. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032-7.
17. Nguyen TT, Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Computational identification of transcriptional regulators in human endotoxemia. PLoS One. 2011;6:e18889.
18. Foteinou P, Calvano S, Lowry S, Androulakis I. Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math Biosci. 2009;217:27-42.
19. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. A physiological model for autonomic heart rate regulation in human endotoxemia. Shock. 2011;35:229.
20. Scheff JD, Mavroudis PD, Calvano SE, Lowry SF, Androulakis IP. Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia. Physiol Genomics. 2011;43:951-64.
21. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Multiscale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol Genomics. 2010;42:5-19.
22. Scheff JD, Mavroudis PD, Foteinou PT, Calvano SE, Androulakis IP. Modeling physiologic variability in human endotoxemia. Crit Rev Biomed Eng. 2012;40:313-22.
23. Scheff JD, Calvano SE, Lowry SF, Androulakis IP. Modeling the influence of circadian rhythms on the acute inflammatory response. J Theor Biol. 2010;264:1068-76.
24. Scheff JD, Mavroudis PD, Calvano SE, Androulakis IP. Translational applications of evaluating physiologic variability in human endotoxemia. J Clin Monit Comput. 2013;27:405-15.
25. Kamisoglu K, Sleight KE, Calvano SE, Coyle SM, Corbett SA, Androulakis IP. Temporal metabolic profiling of plasma during endotoxemia in humans. Shock. 2013;40:519-26.
26. Kosmides AK, Kamisoglu K, Calvano SE, Corbett SA, Androulakis IP. Metabolomic fingerprinting: challenges and opportunities. Crit Rev Biomed Eng. 2013;41:205-21.
27. Kamisoglu K, Calvano SE, Coyle S, Corbett SA, Androulakis IP. Integrated transcriptional and metabolic profiling in human endotoxemia. Shock. 2014;42:499-508.
28. Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5:195ra195.
29. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656-67.
30. Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, Logun C, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics. 2006;25:203-15.
31. Leys C, Ley C, Klein O, Bernard P, Licata L. Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49:764-6.
32. Hampel FR. The influence curve and its role in robust estimation. J Am Stat Assoc. 1974;69:383-93.
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289-300.
34. Visser T, Pillay J, Pickkers P, Leenen LP, Koenderman L. Homology in systemic neutrophil response induced by human experimental endotoxemia and by trauma. Shock. 2012;37:145-51.
35. Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med. 2010;17:383-90.
36. Straub RH, Vogl D, Gross V, Lang B, Scholmerich J, Andus T. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1998;93:2197-202.
37. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A. 2013;110:3507-12.
38. Matzinger P. The danger model: a renewed sense of self. Science. 2002;296:301-5.
39. Cain D, del Arroyo A, Ackland G. Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine. ICMx. 2014;2:1-25.
40. Maslove DM, Wong HR. Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med. 2014;20:204-13.
41. Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, Aibiki M, et al. Abandon the mouse research ship? Not just yet! Shock. 2014;41:463-75.